Immunometabolism Research Scientist with expertise in type 2 diabetes (T2D) mechanisms, specializing in CRISPR-based gene editing (KO/KI, base editing, CRISPRi), genome-wide screening for novel therapeutic targets, and multi-omics validation. Skilled in live imaging of immune-islet interactions and developing translational models (zebrafish, mouse). Pioneered the discovery of NOX2-mediated β-cell death through drug screening and functional assays. Combines strong technical proficiency in immune cell modulation with a deep understanding of metabolic dysregulation in T2D.
NIH-funded Projects in Islet Biology & Immunometabolism
Project 1: Mechanisms of α-Cell Proliferation in Hyperaminoacidemia (R01 DK117147-03)
Project 2: Neutrophil-Mediated β-Cell Death in T2D (R01 DK109407)
Investigated hormonal control of glucose metabolism via experimental design, feed development, and aquaculture studies for NSFC-funded research.
Molecular & Cellular Techniques:
Cell Biology Techniques:
Communication & Mentoring:
Analytical Skills:
Graduate & Postdoctoral:
Undergraduate (Henan University):